サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1375150

中南米の大腸がん診断薬市場の2028年までの予測-地域別分析-モダリティ別、エンドユーザー別

South & Central America Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

出版日
ページ情報
英文 131 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
中南米の大腸がん診断薬市場の2028年までの予測-地域別分析-モダリティ別、エンドユーザー別
出版日: 2023年08月28日
発行: The Insight Partners
ページ情報: 英文 131 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の大腸がん診断薬市場は2023年に7億4,913万米ドルとなり、2028年には10億8,786万米ドルに達すると予測されています。2023年から2028年までのCAGRは7.7%と推定されます。

大腸内視鏡検査における人工知能が中南米の大腸がん診断薬市場を牽引

消化器内科における大腸がん（CRC）の早期発見は、患者に無病生存と全生存への最良の機会を提供します。しかし、大腸内視鏡検査の結果は病変の検出において大きなばらつきを示しています。腺腫検出率（ADR）は、大腸がんスクリーニングのために内視鏡医が実施する大腸内視鏡検査の質を評価するためのゴールドスタンダードです。

大腸がんをはじめとする様々ながんの診断や治療において、AI技術の活用が注目されています。大腸がんを管理するための個別化された新しい戦略のために、様々なAI支援システムが利用可能です。内視鏡検査において、AIは広義にはコンピュータビジョン技術に関連し、コンピュータが視覚的内容を「見て」解釈することを可能にします。機械学習プロセスとディープラーニングにより、AIシステムはゴールドスタンダードを適切な画像にリンクさせることで「正常な」特徴を認識するように訓練することができます。病変検出にコンピュータービジョンを使用することは、消化器内科におけるAIの最初の応用となります。大腸内視鏡検査におけるポリープの発見と認識において、内視鏡検査の質の向上に役立つと思われます。

大腸内視鏡検査におけるAIは、範囲が拡大した新しい分野ではあるが、内視鏡検査の質と患者のケアを向上させる可能性があります。また、大腸内視鏡検査におけるパフォーマンスと品質向上の管理プロセスを変革し、いくつかの重要なパフォーマンス指標を改善することもできます。メドトロニックは、大腸内視鏡検査用のAI搭載GI Geniusモジュールをインドで発売しました。ディープラーニングアルゴリズムとリアルタイムデータを活用したこの革新的なソリューションは、大腸内視鏡検査中の視覚化を強化することで、医師が大腸がんを発見・治療できるようにします。GI GeniusのようなAIアプリケーションはADRの改善につながり、大腸がんの早期発見、病変のより良い臨床管理、組織の詳細な特徴付けを容易にします。このように、大腸がん画像検査へのAIの採用は、今後数年間、中南米の大腸がん診断薬市場に新たな動向をもたらす可能性が高いです。

中南米の大腸がん診断薬市場概要

中南米大腸がん診断薬市場は、ブラジル、アルゼンチン、その他の中南米に区分されます。ブラジル保健省によると、農作物に散布される農薬が原因で大腸がんの症例が大幅に増加しています。このような食品や水の摂取は、大腸がんの発症につながる可能性があります。さらに、大腸がんの有病率は高齢者ほど高いです。Globocan 2020のデータによれば、2020年にはブラジルで約5万5,102人の新規大腸がん症例が記録されました。また、男性では2万7,346例、女性では2万7,756例が報告されています。大腸がんに関する啓発キャンペーンは、特に民間部門からブラジル全土に広がっています。ブラジル腸がん予防協会（ABRAPRECI）と大腸がん予防検診プログラムが開始されました。啓発キャンペーンや検診プログラムの増加により、大腸内視鏡検査の需要が高まっています。さらに、2020年 12月、フランスの診断会社HalioDxは、Diagnosticos da America（DASA）と、同社のImmunoscore大腸がんリスク評価検査をブラジルで販売する契約を締結しました。Immunoscoreは、腫瘍部位の宿主免疫応答を測定することにより、早期大腸がんの再発リスクを予測し、治療戦略の立案に役立てる。契約条件では、ブラジルではサンパウロを拠点とするDASA社が独占販売権を持ち、40の検査施設ネットワークを通じて同検査を提供します。上記の要因から、ブラジルの中南米大腸がん診断薬市場は予測期間中に有利な機会を示す可能性が高いです。

中南米の大腸がん診断薬市場の収益と2028年までの予測（金額）

中南米の大腸がん診断薬市場セグメンテーション

中南米の大腸がん診断薬市場は、モダリティ、エンドユーザー、国別に区分されます。

モダリティ別では、中南米の大腸がん診断薬市場は画像検査と便検査に二分されます。2023年には、画像検査セグメントが中南米の大腸がん診断薬市場でより大きなシェアを占めました。画像検査分野はさらに、大腸内視鏡検査、CTコロノグラフィー、軟性S状結腸鏡検査、カプセル内視鏡検査、その他に区分されます。便ベースの検査市場は、便免疫化学検査（Fecal Immunochemical Test：FIT）、グアイアック法便潜血検査（Guaiac-based Faecal Occult Blood Test：GFOBT）、便DNA検査に細分化されます。

エンドユーザーに基づくと、中南米の大腸がん診断薬市場は病院、診断研究所、がん研究機関、その他に区分されます。2023年には、病院セグメントが中南米大腸がん診断薬市場で最大のシェアを占めました。

国別では、中南米の大腸がん診断薬市場はブラジル、アルゼンチン、その他の南米に区分されます。2023年、ブラジルは中南米大腸がん診断薬市場で最大のシェアを占めました。

Medtronic Plc、Illumina Inc、F. Hoffmann-La Roche Ltd、Quest Diagnostics Inc、Siemens Healthineers AG、Bruker Corp.、Eiken Chemical Co., Ltd.は、中南米の大腸がん診断薬市場に参入している主要企業です。

目次

第1章 イントロダクション

第2章 中南米の大腸がん診断薬市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の大腸がん診断薬市場- 市場情勢

  • イントロダクション
  • 中南米のPEST分析
  • 専門家の見解

第5章 中南米の大腸がん診断薬市場：主要市場力学

  • 市場促進要因
    • 大腸がんの有病率の増加
    • 新製品の上市
  • 主な阻害要因
    • 糞便免疫化学検査（FIT）に基づくスクリーニングの精度の低さ
  • 今後の動向
    • 大腸内視鏡検査における人工知能
  • 影響分析

第6章 大腸がん診断薬市場-中南米分析

  • 中南米の大腸がん診断薬市場収益と予測分析

第7章 中南米大腸がん診断薬市場：2028年までの収益と予測：モダリティ別

  • イントロダクション
  • 中南米の大腸がん診断薬市場：2022年・2028年のモダリティ別売上高シェア（%）
  • 便検査
  • 画像検査

第8章 中南米大腸がん診断薬市場：2028年までの収益と予測：エンドユーザー別

  • イントロダクション
  • 中南米の大腸がん診断薬市場：2022年・2028年のエンドユーザー別売上高シェア（%）
  • 病院
  • 診断研究所
  • がん研究機関
  • その他

第9章 中南米の大腸がん診断薬市場：2028年までの収益と予測：国別分析

  • 中南米
    • ブラジル
    • アルゼンチン
    • その他の中南米

第10章 中南米の大腸がん診断薬市場-業界情勢

  • イントロダクション
  • 無機的成長戦略
  • 概要
  • 有機的成長戦略
  • 概要

第11章 企業プロファイル

  • Medtronic Plc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Inc
  • Siemens Healthineers AG
  • Bruker Corp
  • Eiken Chemical Co., Ltd.

第12章 付録

図表

List Of Tables

  • Table 1. South & Central America Colorectal Cancer Diagnostics Market -Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Brazil Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Brazil Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Brazil Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Brazil Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Argentina Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Argentina Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Argentina Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Argentina Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Rest of South & Central America Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Rest of South & Central America Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Recent Inorganic Growth Strategies in the South & Central America colorectal cancer diagnostics market
  • Table 15. Recent Organic Growth Strategies in the South & Central America colorectal cancer diagnostics market
  • Table 16. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Colorectal Cancer Diagnostics Market Segmentation
  • Figure 2. South & Central America Colorectal Cancer Diagnostics Market, by Country
  • Figure 3. South & Central America Colorectal Cancer Diagnostics Market Overview
  • Figure 4. Imaging Tests Segment Held Largest Share of Modality Segment in South & Central America Colorectal Cancer Diagnostics Market
  • Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. South and Central America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. South & Central America Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints
  • Figure 9. South & Central America Colorectal Cancer Diagnostics Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
  • Figure 11. Stool Based Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Faecal Immunochemical Test (FIT): South & Central Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Guaiac-based Faecal Occult Blood Test (gFOBT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Stool DNA Test: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Imaging Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Colonoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. CT Colonography: South & Central American Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Flexible Sigmoidoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Capsule Endoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 22. Hospitals: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Diagnostic Laboratories: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Cancer Research Institutes: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. South & Central America: Colorectal Cancer Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 27. South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
  • Figure 28. Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028835

The South & Central America colorectal cancer diagnostics market was valued at US$ 749.13 million in 2023 and is expected to reach US$ 1,087.86 million by 2028. It is estimated to register a CAGR of 7.7% from 2023 to 2028.

Artificial Intelligence in Colonoscopy Drive South & Central America Colorectal Cancer Diagnostics Market

The early detection of colorectal cancer (CRC) in gastroenterology offers patients the best opportunity for disease-free and overall survival. However, colonoscopy results show significant variations in lesion detection. The adenoma detection rate (ADR) is the gold standard for evaluating the quality of colonoscopy performed by endoscopists for colorectal cancer screening.

The use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer, is now gaining substantial attention. Various AI-supporting systems are available for personalized and novel strategies for managing colorectal cancer. In endoscopy, AI broadly relates to a computer vision technology, allowing computers to "see" and interpret visual content. Through machine learning processes and deep learning, AI systems can be trained to recognize "normal" characteristics by linking gold standards to suitable images. Using computer vision for lesion detection will be the first application of AI in gastroenterology. It would help improve the quality of endoscopy practices in finding and recognizing polyps on colonoscopy.

Although AI in colonoscopy is a new field with an extended scope, it can potentially improve the quality of endoscopic examinations and patient care. It can also transform the process of managing performance and quality betterment in colonoscopy, alongside improving several key performance measures. Medtronic has launched its AI-powered GI Genius module for colonoscopy in India. This transformative solution that leans on deep learning algorithms and real-time data empowers physicians to detect and treat colorectal cancer by offering enhanced visualization during colonoscopy. AI applications such as the GI Genius can lead to an improved ADR, facilitating the earlier detection of colorectal cancer, better clinical management of lesions, and detailed characterization of tissues. Thus, the adoption of AI for colorectal cancer imaging tests is likely to bring new trends in the South & Central America colorectal cancer diagnostics market in the coming years.

South & Central America Colorectal Cancer Diagnostics Market Overview

The South & Central America colorectal cancer diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. According to the Brazilian Ministry of Health, cases of colon cancer have increased significantly due to the pesticides applied to the crops. Consumption of such food and water can lead to the development of colon cancer. In addition, the prevalence of colorectal cancer is higher among older adults. In 2020, around 55,102 new colorectal cancer cases were recorded in Brazil, as per Globocan 2020 data. In addition, 27,346 cases were reported in males and 27,756 in females. Awareness campaigns regarding colorectal cancer have grown across Brazil, especially from the private sector. The Brazilian Association of Intestinal Cancer Prevention (ABRAPRECI) and the Colorectal Cancer Prevention and Screening Program have been initiated. The growth in awareness campaigns and screening programs has increased the demand for colonoscopy services. In addition, in December 2020, a French diagnostic firm HalioDx signed an agreement with Diagnosticos da America (DASA) to distribute its Immunoscore colon cancer risk-assessment test in Brazil. Immunoscore assists in predicting the risk of relapse in early-stage colon cancer by measuring host immune responses at tumor sites, which helps plan treatment strategies. Under the agreement terms, in Brazil, Sao Paulo-based DASA has exclusive distribution rights to the test, offering it through 40 laboratory networks. Owing to the above-mentioned factors, the South & Central America colorectal cancer diagnostics market in Brazil is likely to witness lucrative opportunities during the forecast period.

South & Central America Colorectal Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Colorectal Cancer Diagnostics Market Segmentation

The South & Central America colorectal cancer diagnostics market is segmented into modality, end user, and country.

Based on modality, the South & Central America colorectal cancer diagnostics market is bifurcated into imaging tests and stool-based tests. In 2023, the imaging tests segment held a larger share of the South & Central America colorectal cancer diagnostics market. The market for the imaging tests segment is further segmented into colonoscopy, ct colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gfobt), and stool DNA test.

Based on end user, the South & Central America colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2023, the hospitals segment held the largest share of the South & Central America colorectal cancer diagnostics market.

Based on country, the South & Central America colorectal cancer diagnostics market is segmented into Brazil, Argentina, and Rest of South & Central America. In 2023, Brazil accounted for the largest share of the South & Central America colorectal cancer diagnostics market.

Medtronic Plc, Illumina Inc, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Siemens Healthineers AG, Bruker Corp.; and Eiken Chemical Co., Ltd. are the leading companies operating in the South & Central America colorectal cancer diagnostics market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America colorectal cancer diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America colorectal cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the colorectal cancer diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Colorectal Cancer Diagnostics Market - by Modality
    • 1.3.2 South & Central America Colorectal Cancer Diagnostics Market - by End User
    • 1.3.3 South & Central America Colorectal Cancer Diagnostics Market - by Country

2. South & Central America Colorectal Cancer Diagnostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Colorectal Cancer Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Colorectal Cancer Diagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Colorectal Cancer
    • 5.1.2 Launches of New Products
  • 5.2 Key Restraints
    • 5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
  • 5.3 Future Trends
    • 5.3.1 Artificial Intelligence in Colonoscopy
  • 5.4 Impact Analysis

6. Colorectal Cancer Diagnostics Market - South & Central America Analysis

  • 6.1 South & Central America Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis

7. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - by Modality

  • 7.1 Overview
  • 7.2 South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
  • 7.3 Stool Based Tests
    • 7.3.1 Overview
    • 7.3.2 Stool Based Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.3 Faecal Immunochemical Test (FIT)
      • 7.3.3.1 Overview
      • 7.3.3.2 Faecal Immunochemical Test (FIT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
      • 7.3.4.1 Overview
      • 7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.5 Stool DNA Test
      • 7.3.5.1 Overview
      • 7.3.5.2 Stool DNA Test: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Imaging Tests
    • 7.4.1 Overview
    • 7.4.2 Imaging Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.3 Colonoscopy
      • 7.4.3.1 Overview
      • 7.4.3.2 Colonoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.4 CT Colonography
      • 7.4.4.1 Overview
      • 7.4.4.2 CT Colonography: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.5 Flexible Sigmoidoscopy
      • 7.4.5.1 Overview
      • 7.4.5.2 Flexible Sigmoidoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.6 Capsule Endoscopy
      • 7.4.6.1 Overview
      • 7.4.6.2 Capsule Endoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.7 Others
      • 7.4.7.1 Overview
      • 7.4.7.2 Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - by End User

  • 8.1 Overview
  • 8.2 South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Diagnostic Laboratories
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Laboratories: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Cancer Research Institutes
    • 8.5.1 Overview
    • 8.5.2 Cancer Research Institutes: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - Country Analysis

  • 9.1 Overview
    • 9.1.1 South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
      • 9.1.1.1 Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.3 Brazil: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
        • 9.1.1.1.3.1 Brazil: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
        • 9.1.1.1.3.2 Brazil: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020-2028 (US$ Million)
        • 9.1.1.1.4 Brazil: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.2 Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.3 Argentina: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
        • 9.1.1.2.3.1 Argentina: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
        • 9.1.1.2.3.2 Argentina: Colorectal Cancer Diagnostics Market, For Stool-Based Tests, 2020-2028 (US$ Million)
        • 9.1.1.2.4 Argentina: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
        • 9.1.1.3.3.1 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
        • 9.1.1.3.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020-2028 (US$ Million)
        • 9.1.1.3.4 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)

10. South & Central America Colorectal Cancer Diagnostics Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Inorganic Growth Strategies
    • 10.2.1 Overview
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Illumina Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 F. Hoffmann-La Roche Ltd
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Quest Diagnostics Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Siemens Healthineers AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Bruker Corp
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Eiken Chemical Co., Ltd.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms